AUS
NZ
UK
CA
USA
IND
Healthcare
A positive outcome from the AGM has prompted a rise in the shares of Fusion Antibodies
October 08, 2024 12:19 PM BST| By Team Kalkine MediaHighlights:,Fusion Antibodies PLC reports significant revenue growth, with expected first-half revenues reaching £1.2 million, more than double the previous year’s figure.,The company achieves a notable improvement in gross margin, rising to 29% comp...
ProBiotix Health Shares Q3 2024 Trading Update with Continued Growth in Sales and Profitability
October 08, 2024 08:51 AM BST| By Team Kalkine MediaHighlights,ProBiotix reported a 39% increase in sales, reaching £1.525 million compared to £1.099 million in 2023.,A product launch on Amazon and in 2,000 Target stores is driving strong growth in the US market, with more sales pushes planned for Q4...
AstraZeneca has acquired a license from CSPC in China for a cholesterol treatment
October 07, 2024 03:32 PM BST| By Team Kalkine MediaHighlights:,AstraZeneca has acquired a license for a novel cholesterol-lowering drug, YS2302018, from CSPC Pharmaceutical for an initial payment of $100 million.,The drug targets the formation of lipoproteins linked to coronary artery disease and str...
Futura Medical Secures $5 Million Milestone Payment Following US Launch of Eroxon
October 07, 2024 11:46 AM BST| By Team Kalkine MediaHighlights:,Milestone Payment Secured,: Futura Medical received a $5 million payment following the US launch of its over-the-counter erectile dysfunction gel, Eroxon.,Significant Market Opportunity,: Analysts project peak Eroxon sales of £176 million...
ValiRx Subsidiary Partners with BioRep to Enhance Drug Screening Services
October 07, 2024 08:56 AM BST| By Team Kalkine MediaKey Points:,Inaphaea BioLabs has executed a co-marketing agreement with BioRep to enhance drug screening services and patient-derived cells.,BioRep will provide backup sample storage and logistics, along with molecular biology services in mainland Eu...
Faron Pharmaceuticals to Host Capital Markets Day on 22 October 2024. What’s Expected?
October 07, 2024 08:37 AM BST| By Team Kalkine MediaKey Points:,Faron Pharmaceuticals will host a Capital Markets Day on October 22, 2024, featuring key presentations from leading experts.,The agenda includes discussions on the company’s strategy, updated clinical data for bexmarilimab, and market ass...
Life Science REIT Backed by Berenberg's Optimistic Forecast, UK Growth Expected
October 04, 2024 03:32 PM BST| By Team Kalkine MediaHighlights:,Strong growth potential:,Berenberg reaffirms its "buy" rating for Life Science REIT, highlighting a price target of 57p per share.,Undervalued stock:,The company trades at a 46% discount to NAV, offering a 5% dividend yield with strong le...
China and Southeast Asia Hurdles Lead to Revenue Warning from Eco Animal Health
October 01, 2024 11:57 AM BST| By Team Kalkine MediaHighlights:,Eco Animal Health warns full-year revenues will fall below expectations due to challenges in China and Southeast Asia.,Strong performance in Brazil, India, and the US bolstered the company’s market share, with Aivlosin driving growth.,The...
Haleon (LSE:HLN) shares update on off-market transaction with Pfizer
October 01, 2024 08:43 AM BST| By Team Kalkine MediaHaleon plc (LSE:HLN) has announced that it will purchase 60,526,315 ordinary shares from Pfizer Inc. as part of an off-market transaction. This agreement follows the company’s previous announcement on September 30, 2024, and is being carried out in a...
Creo Medical Secures £12 Million to Fuel Growth and Target Break-Even
October 01, 2024 08:05 AM BST| By Team Kalkine MediaHighlights,Creo Medical Group PLC successfully raises £12 million through a share placement to support growth.,Additional stock offerings could generate up to £5 million, bringing total funding to £40 million.,Funds will facilitate increased producti...
FTSE 100 Live: London Shares Poised for Uptick Ahead of Key Economic Update
October 01, 2024 07:45 AM BST| By Team Kalkine MediaHighlights,Haleon PLC completes a share repurchase agreement with Pfizer Inc, totaling £230 million.,The transaction concludes Haleon’s £500 million share buyback program initiated in August.,Pfizer’s stake in Haleon is reduced from 22.6% to 15%.,Hal...
Haleon Acquires Shares as Pfizer Reduces Its Position
October 01, 2024 07:35 AM BST| By Team Kalkine MediaHighlights,Haleon PLC completes a significant share repurchase from Pfizer Inc.,The transaction concludes a £500 million share buyback program initiated in August.,Pfizer’s ownership stake in Haleon will decrease from 22.6% to 15%.,Haleon PLC,{LSE:HL...
Celadon Pharmaceuticals Announces CFO Jonathan Turner’s Departure
September 30, 2024 05:21 PM BST| By Team Kalkine MediaHighlights:,Celadon Pharmaceuticals announced CFO Jonathan Turner will step down from his position on 27 December.,The company has begun the search for a successor, with an update to follow once a new CFO is appointed.,Shares in Celadon Pharmaceutica...
Ondine Biomedical (LSE:OBI) records 101% jump in revenue in 1HFY24, shares on radar
September 30, 2024 08:20 AM BST| By Team Kalkine MediaOndine Biomedical Inc. (LSE:OBI),, a prominent provider of light-activated antimicrobial technology aimed at preventing and treating hospital infections, has reported robust operational results for the first half of 2024. The company highlights signi...
Avacta Group (LSE:AVCT) releases interim results, eyes NASDAQ listing
September 30, 2024 07:58 AM BST| By Team Kalkine MediaAvacta Group plc (LSE:AVCT), a life sciences company known for developing innovative oncology drugs and diagnostics, has released its unaudited interim results for the six months ending June 30, 2024. The company has made significant strides towards...
hVIVO Introduces hLAB Standalone Services at New Canary Wharf facility
September 30, 2024 07:46 AM BST| By Team Kalkine MediaHighlights,Launch of hLAB standalone services expands virology and immunology laboratory capabilities.,New Canary Wharf facility increases laboratory capacity, allowing for advanced research.,Introduction of a biobank and CL-3 facility enhances suppo...
ValiRx Reports Reduced Losses and Operational Milestones
September 27, 2024 04:55 PM BST| By Team Kalkine MediaHighlights:,Narrowed Losses:,ValiRx reported a comprehensive loss of £0.97 million, an improvement from the previous year’s loss.,Operational Milestones:,The company signed its first U.S. customer and expanded its Inaphaea Biobank to include advanced...
OptiBiotix Health Reports Revenue Decline for First Half of the Year
September 27, 2024 04:40 PM BST| By Team Kalkine MediaHighlights:,Revenue Decline:,OptiBiotix Health reported a 21.3% decrease in revenue, totaling £0.28 million for the first half of the year.,Strategic Focus:,The company is enhancing operational efficiency and expanding partnerships to improve market...
Totally Secures New Contracts to Enhance NHS Services
September 27, 2024 04:40 PM BST| By Team Kalkine MediaHighlights:,New Contracts Secured:,Totally plc has obtained a £5.0 million insourcing contract and a £1.1 million extension for its NHS 111 services.,Expansion Plans:,The contracts enhance Totally’s presence across the north of England, improving pat...
Roquefort Therapeutics' Innovative Cancer Approach Attracts Attention from Big Pharma and Private Equity
September 27, 2024 09:09 AM BST| By Team Kalkine MediaHighlights,Innovative Drug Development,: Roquefort Therapeutics is advancing first-in-class oncology drugs, focusing on high-growth therapeutic areas with the potential for lucrative partnerships.,Strategic Partnerships,: The company has signed its f...
